Information and interesting ideas

Topics posted here will be in the realm of bioanalysis and biomarkers as part of new therapeutic development, with the occasional post of scientific topics that I find interesting.

Friday, January 20, 2023

Welcome

In past positions, sharing information to staff and collaborators that was of interest or essential to their success was a daily priority for me. I look to continue that practice with this blog.  I'll post a variety of information, including:

- science related to developing new therapeutics

- updates on bioanalytical news

- updates on biomarkers and diseases

- regulatory news (new draft and final regulations, workshops, webinars) covering GLP, GCP, CLIA, and IVDR

-  interesting topics 

I plan to post a few times a week and look forward to hearing your comments on the post topics. Please follow me to receive notification of new posts.

No comments:

Post a Comment

FDA and CMS issue statement on LDTs: Americans Deserve Accurate and Reliable Diagnostic Tests, Wherever They Are Made

This joint statement notes the evolution of Laboratory Developed Tests (LDTs) from the initial rule and approach the FDA had for oversite, a...